MedTrace Logo

Prevalence of Sarcopenia in Stroke Patients

NCT07492849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-04-02

No results posted yet for this study

Summary

The goal of this observational study is to analyze the characteristics of sarcopenia-related variables in post-acute and chronic stroke patients using various clinical measurement tools. The study also aims to examine the differences in these variables based on age groups (40-65 years and \>65 years), sex, and stroke severity.

The main questions it aims to answer are:

What are the differences in sarcopenia prevalence and related indicators between post-acute care and chronic stroke patients? How do age, sex, and stroke severity affect these sarcopenia-related measurements?

Participants will include stroke patients aged 40 and older with adequate cognitive and physical function to complete sarcopenia screening and questionnaires. They will be divided into two groups:

Group 1: Chronic stroke patients (n ≥ 75) Group 2: Post-acute care stroke patients (n ≥ 25)

All participants will undergo both objective and subjective assessments, including:

Objective assessments: Body composition, quadriceps strength, quadriceps and gastrocnemius muscle thickness via ultrasound, calf circumference, dominant hand grip strength, walking speed, SARC-F questionnaire, and the Mini Nutritional Assessment.

Subjective assessment: EQ-5D health-related quality of life questionnaire. The collected data will be analyzed to compare the prevalence and characteristics of sarcopenia between the two stroke groups and across different subgroups by age and sex.

Conditions

  • Sarcopenia
  • Cerebral Stroke
  • Cerebral Vascular Accident (CVA)/Stroke

Interventions

DIAGNOSTIC_TEST

Objective assessments

include sarcopenia-related indicators such as body composition, quadriceps muscle strength measurement, quadriceps muscle thickness via ultrasound, gastrocnemius muscle thickness via ultrasound, calf circumference, dominant hand grip strength, walking speed, the SARC-F questionnaire, and the Mini Nutritional Assessment scale.

DIAGNOSTIC_TEST

Subjective assessment

involves the EQ-5D questionnaire to evaluate health-related quality of life

Sponsors & Collaborators

  • Cishan Hospital, Ministry of Health and Welfare

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2025-10-04
Completion
2026-03-01

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07492849 on ClinicalTrials.gov